Development and Validation of the Pediatric Nausea Assessment Tool for Use in Children Receiving Antineoplastic Agents

Study Objective. To develop and validate an instrument to assess nausea intensity in children aged 4–18 years.

[1]  L. Rajmil.  Health measurement scales. A practical guide to their development and use, 3rd ed , 2005 .

[2]  N. Young,et al.  Words used by children and their primary caregivers for private body parts and functions. , 2003, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[3]  Charles G. Martin,et al.  Measuring chemotherapy‐induced nausea and emesis , 2003, Cancer.

[4]  L. Dupuis,et al.  Outcomes of antiemetic prophylaxis in children undergoing bone marrow transplantation , 2002, Bone Marrow Transplantation.

[5]  Mark L. Greenberg,et al.  Delayed nausea and vomiting in children receiving antineoplastics. , 2001, Medical and pediatric oncology.

[6]  M. Holdsworth,et al.  Computerized System for Outcomes-Based Antiemetic Therapy in Children , 2000, The Annals of pharmacotherapy.

[7]  F. Wright,et al.  Pediatric Nausea, Vomiting, and Retching Guide , 2000 .

[8]  P. Orchard,et al.  A prospective randomized trial of the anti-emetic efficacy of ondansetron and granisetron during bone marrow transplantation. , 1999, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[9]  A. Kürekçi,et al.  Comparison of the efficacy and side-effects of ondansetron and metoclopramide-diphenhydramine administered to control nausea and vomiting in children treated with antineoplastic chemotherapy: a prospective randomized study , 1998, European Journal of Pediatrics.

[10]  M. Tonato,et al.  Methodology of antiemetic trials: response assessment, evaluation of new agents and definition of chemotherapy emetogenicity , 1998, Supportive Care in Cancer.

[11]  P. Butow,et al.  On the receiving end. V: Patient perceptions of the side effects of cancer chemotherapy in 1993. , 1996, Annals of oncology : official journal of the European Society for Medical Oncology.

[12]  C. Pinkerton,et al.  Randomised comparison of ondansetron and metoclopramide plus dexamethasone for chemotherapy induced emesis. , 1995, Archives of disease in childhood.

[13]  G. Zimmerman,et al.  Randomized Double‐Blind Crossover Ondansetron‐Dexamethasone versus Ondansetron‐Placebo Study for the Treatment of Chemotherapy‐Induced Nausea and Vomiting in Pediatric Patients with Malignancies , 1995, Journal of pediatric hematology/oncology.

[14]  M. Holdsworth,et al.  Assessment of Chemotherapy-Induced Emesis and Evaluation of a Reduced-Dose Intravenous Ondansetron Regimen in Pediatric Outpatients with Leukemia , 1995, The Annals of pharmacotherapy.

[15]  M. Relling,et al.  Chemotherapy Induced Nausea and Emesis in Pediatric Cancer Patients: External Validity of Child and Parent Emesis Ratings , 1993, Journal of developmental and behavioral pediatrics : JDBP.

[16]  A. Favero,et al.  Issues in the measurement of nausea. , 1992, The British journal of cancer. Supplement.

[17]  S. Gambihler,et al.  In vitro interaction of lithotripter shock waves and cytotoxic drugs. , 1992, British Journal of Cancer.

[18]  P. Hinds,et al.  Measuring Symptom Distress in Adolescents With Cancer , 1992, Journal of pediatric oncology nursing : official journal of the Association of Pediatric Oncology Nurses.

[19]  L. Zeltzer,et al.  Can children understand and use a rating scale to quantify somatic symptoms: Assessment of nausea and vomiting as a model. , 1988, Journal of consulting and clinical psychology.

[20]  L. Zeltzer,et al.  The effectiveness of behavioral intervention for reduction of nausea and vomiting in children and adolescents receiving chemotherapy. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  M. Johnson,et al.  Development of reliable and valid measures of nausea and vomiting , 1984, Cancer nursing.

[22]  S B Kaye,et al.  On the receiving end--patient perception of the side-effects of cancer chemotherapy. , 1983, European journal of cancer & clinical oncology.

[23]  H. Orimo,et al.  Effects of carvedilol on common carotid arterial flow, peripheral hemodynamics, and hemorheologic variables in hypertension , 2005, European Journal of Clinical Pharmacology.

[24]  A. Favero,et al.  Assessment of nausea , 2004, European Journal of Clinical Pharmacology.

[25]  C. Chambers,et al.  Developmental differences in children's use of rating scales. , 2002, Journal of pediatric psychology.

[26]  S. Phipps,et al.  Assessment of health‐related quality of life in acute in‐patient settings: Use of the BASES instrument in children undergoing bone marrow transplantation , 1999, International journal of cancer. Supplement = Journal international du cancer. Supplement.

[27]  R. Woodgate,et al.  Symptom distress in children with cancer: the need to adopt a meaning-centered approach. , 1998, Journal of pediatric oncology nursing : official journal of the Association of Pediatric Oncology Nurses.

[28]  J. Verweij,et al.  Patient perceptions of the side-effects of chemotherapy: the influence of 5HT3 antagonists. , 1997, British Journal of Cancer.

[29]  M. Kris,et al.  Proposal for classifying the acute emetogenicity of cancer chemotherapy. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  M. Yaster,et al.  Pain in Infants, Children, and Adolescents , 1993 .

[31]  D. Wong,et al.  Pain in children: comparison of assessment scales. , 1988, The Oklahoma nurse.

[32]  L. Zeltzer,et al.  A prospective assessment of chemotherapy-related nausea and vomiting in children with cancer. , 1984, The American journal of pediatric hematology/oncology.

[33]  R. Sitgreaves.  Psychometric theory (2nd ed.). , 1979 .